Scottsdale Research Institute

In Phoenix, Scottsdale Research Institute is a research institute focused on whole plant and fungal medicines. Its DEA-licensed laboratory cultivates plants and fungi for studies and supplies these medicines on a limited basis to research partners across the country. The institute conducts research on naturally occurring compounds, including cannabis and psilocybin, with attention to potential applications and patient access. It has studied cannabis as a PTSD treatment for veterans and completed a Phase 1 whole-mushroom psilocybin trial. SRI also works with researchers, community stakeholders, and government officials on policy and regulatory issues affecting controlled plant substances. Its ongoing work includes research and regulatory efforts related to the federal Right to Try pathway.